Vericel forecasts $326M-$336M 2026 revenue as BARDA-backed NexoBrid procurement begins in H2
Vericel Corporation · BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) · Now $32.82
+3.1% in 7d after detection
Post-detection moves
1h
—
1d
-1.6%
3d
-1.9%
7d
+3.1%
30d
—
Get alerts like this in real time
Push notifications the moment a signal fires. No spam, no crypto, no fluff.
Download for iOS